Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2006Nicotine & Tobacco Research

Clinical laboratory evaluation of potential reduced exposure products for smokers

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAlison BrelandVirginia Commonwealth UniversityBKBethea A. KleykampUniversity of Maryland, BaltimoreTEThomas EissenbergVirginia Commonwealth University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Breland et al. (2006) studied this question.

synapsesocial.com/papers/6a228d7c3cc05cab01ddb4b0https://doi.org/10.1080/14622200600789585
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking2004 · 29 citations
  2. 2The development and initial validation of a questionnaire on smoking urges1991 · 991 citations
  3. 3Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit2000 · 55 citations
  4. 4Signs and Symptoms of Tobacco Withdrawal1986 · 1,676 citations
  5. 5Evaluating acute effects of potential reduced-exposure products for smokers: Clinical laboratory methodology2002 · 72 citations